Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02963558 · ClinicalTrials.gov registry record · NA

A Study Promoting Critical Illness Recovery in the Elderly

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT02963558: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT02963558 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02963558, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

This proposal will test the hypothesis that EARLY application of a novel early rehabilitation therapy in critically ill patients will improve functional outcomes, and change the functional trajectory of this population. A pilot study of early mobilization with a cycle ergometer will be performed and translate into humans the pre-clinical mechanisms that may mediate the effects of early mobility. A second phase of the study was added in September 2019, which will focus on clinical outcomes.

Primary Outcome

Feasibility will be assessed by quantifying the ability to apply the MOTOmed device for at least a 15-minute session within 48 hours of randomization and meeting safety criteria.

Interventions

  • DEVICE cycle ergometry

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2017-05-30
Est. Completion 2021-03-11
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT02963558 record still lists

NCT02963558 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which cycle ergometry is the first listed.

NCT02963558 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02963558 about?

NCT02963558 is a clinical study titled "A Study Promoting Critical Illness Recovery in the Elderly". This proposal will test the hypothesis that EARLY application of a novel early rehabilitation therapy in critically ill patients will improve functional outcomes, and change the functional trajectory of this population. A pilot study of early mobilization with a cycle ergometer will be performed and...

What is the current status of trial NCT02963558?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2017-05-30. Estimated completion is 2021-03-11.

What interventions are being tested in trial NCT02963558?

The interventions under investigation include: cycle ergometry (DEVICE).

Who is sponsoring clinical trial NCT02963558?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02963558's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02963558, the US trial registry maintained by the National Library of Medicine. NCT02963558 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.